Related Experiment Video

Updated: May 8, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

APOBEC3B mutagenesis in cancer

Kawai J Kuong, Lawrence A Loeb

    Nature Genetics
    |August 30, 2013
    PubMed

    Insights

    The enzyme APOBEC3B is linked to mutations in several cancers, including cervical and breast cancer. This suggests a connection between immune responses, viral infections, and cancer development.

    Area of Science:

    • Oncology
    • Immunology
    • Virology

    Background:

    • Recent evidence implicates the enzyme Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B (APOBEC3B) as a significant source of mutations in various human cancers.
    • APOBEC3B's role has been identified in the mutagenesis of cervical, bladder, lung, head and neck, and breast cancers.

    Discussion:

    • APOBEC enzymes are integral to innate immune responses, particularly in combating retroviral infections.
    • The findings suggest a complex interplay between cellular mutagenesis, the immune system, and viral activity in the etiology of cancer.

    Key Insights:

    • APOBEC3B is a key mutagenic factor in multiple cancer types.
    • A link exists between innate immunity, viral infections, and cancer mutagenesis.
    • Understanding APOBEC3B's role may reveal new therapeutic strategies for cancer treatment.

    Outlook:

    • Further research into APOBEC3B's mechanisms could elucidate its role in carcinogenesis.
    • Targeting APOBEC3B activity may offer novel avenues for cancer prevention and therapy.
    • Investigating the interplay between viral infections and APOBEC3B could lead to advancements in onco-immunology.

    More Related Videos

    Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells11:06

    Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

    Published on: February 24, 2014

    Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

    Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

    Published on: February 17, 2011

    Related Concept Videos

    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    In vitro Mutagenesis01:16

    In vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...